Novel therapeutic approaches beyond the serotonin receptor

Biological Psychiatry

Volumn 44, Issue 5, 1998, Pages 324-335

  Duman, Ronald S ^a  

^a Laboratory of Molecular Psychiatry   (United States)

Author keywords

Antidepressant; Cyclic amp; Hippocampus; Neurotrophic factor; Phosphodiesterase; Stress

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; ADENYLATE CYCLASE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; COCAINE; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; DESIPRAMINE; DIPYRIDAMOLE; FLUOXETINE; HALOPERIDOL; LITHIUM; MIANSERIN; MILRINONE; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; ROLIPRAM; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRIFLUOPERAZINE; ZAPRINAST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DEPRESSION; DRUG MECHANISM; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SECOND MESSENGER; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; STRESS;

EID: 0031681434     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00031-6     Document Type: Review

References (57)

1. Aghajanian G.K., Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology. 36:1997;589-599.
2. Bersudsky Y., Kotler M., Shifrin M., Belmaker R.H. A preliminary study of possible psychoactive effects of intravenous forskolin in depressed and schizophrenic patients. J Neural Trans Gen Sect. 103:1996;1463-1467.
3. 4 receptor activation in the rat hippocampus. Naunyn Schmeidebergs Arch Pharmacol. 355:1997;14-19.
4. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci. 15:1994;220-226.
5. Bremner J.D., Randall P., Scott T.M., Bronen R.A., Seibyl J.P., Southwick S.M., et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry. 152:1995;973-981.
6. Colin S.F., Chang H.-C., Mollner S., Pfeuffer T., Reed R.R., Duman R.S., et al. Chronic lithium regulates the expression of adenylate cyclase and Giα in rat cerebral cortex. Proc Natl Acad Sci USA. 88:1991;10634-10637.
7. Condorelli D.F., Dell'Albani P., Mudo G., Timmusk T., Belluardo N. Expression of neurotrophins and their receptors in primary astroglial cultures Induction by cAMP elevating agents . J Neurochem. 63:1994;509-516.
8. Conti M., Nemoz G., Sette C., Vicini E. Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocr Rev. 16:1995;370-389.
9. Duman R.S., Nestler E.J. Signal transduction pathways for catecholamine receptors. Meltzer H. Psychopharmacology The Fourth Generation . 1995;303-320 Raven Press, New York.
10. Duman RS, Nestler EJ (in press): Cyclic nucleotides in the nervous system. In: Siegel G, Agranoff B, Albers RW, Molinoff P, editors. Basic Neurochemistry, 6th ed. New York: Raven Press.
11. Duman R.S., Heninger G.R., Nestler E.J. Adaptations of receptor-coupled signal transduction pathways underlying stress- and drug-induced neural plasticity. J Nerv Ment Dis. 182:1994;692-700.
12. Duman R.S., Vaidya V.A., Nibuya M., Morinobu S., Rydelek Fitzgerald L. Stress, antidepressant treatments, and neurotrophic factors Molecular and cellular mechanisms . Neuroscientist. 1:1995;351-360.
13. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry. 54:1997;597-606.
14. Ghosh A., Greenberg M.E. Calcium signaling in neurons Molecular mechanisms and cellular consequences . Science. 268:1995;239-247.
15. Horowski R., Sastre-Y-Hernandez M. Clinical effects of the neurotrophic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients Global evaluation of the preliminary reports . Curr Ther Res. 38:1985;23-29.
16. Hudson C.J., Young L.T., Li P.P., Warsh J.J. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse. 13:1993;278-293.
17. Konradi C., Cole R.L., Heckers S., Hyman S.E. Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J Neurosci. 14:1994;5623-5634.
18. Lindsay R.M., Wiegand S.J., Anthony Altar C.A., DiStefano P.S. Neurotrophic factors From molecule to man . Trends Neurosci. 17:1994;182-190.
19. Lindvall O., Kokaia Z., Bengzon J., Elmer E., Kokaia M. Neurotrophins and brain insults. Trends Neurosci. 17:1994;490-496.
20. Magarinos A.M., McEwen B.S., Flugge G., Fuchs E. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci. 16:1996;3534-3540.
21. Malison R., Price L.H., Nestler E.J., Heninger G.R., Duman R.S. Efficacy of papaverine addition in treatment-refractory major depression. Am J Psychiatry. 154:1997;579-580.
22. Mamounas L.A., Blue M.E., Siuciak J.A., Anthony Altar C. BDNF promotes the survival and sprouting of serotonergic axons in the rat brain. J Neurosci. 15:1995;7929-7939.
23. Manji H.K., Potter W.C., Lenox R.H. Signal transduction pathways. Arch Gen Psychiatry. 52:1995;531-543.
24. Menkes D.B., Rasenick M.M., Wheeler M.A., Bitensky M.W. Guanosine triphosphate activation of brain adenylate cyclase Enhancement by long-term antidepressant treatment . Science. 129:1983;65-67.
25. Meyer T.E., Habener J.F. Cyclic adenosine 3′,5′-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocr Rev. 14:1993;269-290.
26. Nestler EJ, Duman RS (in press): G-proteins. In: Siegel G, Agranoff B, Albers RW, Molinoff P, editors. Basic Neurochemistry, 6th ed. New York: Raven Press.
27. Nestler E.J., Terwilliger R.Z., Duman R.S. Chronic antidepressant administration alters the subcellular distribution of cAMP-dependent protein kinase in rat frontal cortex. J Neurochem. 53:1989;1644-1647.
28. Newman M.E., Ben-Zeev A., Lerer B. Chloroamphetamine did not prevent the effects of chronic antidepressants on 5-HT inhibition of the effects of forskolin-stimulated adenylate cyclase in rat hippocampus. Eur J Pharmacol. 207:1991;209-213.
29. Newman M.E., Shapira B., Lerer B. Regulation of 5-HT1A receptor function in rat hippocampus by short- and long-term administration of 5-HT1A agonists and antidepressants. J Pharmacol Exp Ther. 260:1992;16-20.
30. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 15:1995;7539-7547.
31. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci. 16:1996;2365-2372.
32. O'Donnell J.M. Antidepressant-like effects of rolipram and other inhibitors of cyclic AMP phosphodiesterase on behavior maintained by differential reinforcement of low response rate. J Pharmacol Exp Ther. 264:1993;1168-1178.
33. Ozawa H., Rasenick M.M. Chronic electroconvulsive treatment augments coupling of the GTP-binding protein Gs to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. J Neurochem. 56:1991;330-338.
34. Perez J., Tinelli D., Brunello N., Racagni G. cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment. Eur J Pharmacol. 172:1989;305-316.
35. Perez J., Tinelli D., Bianchi E., Brunello N., Racagni G. cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity. Neuropsychopharmacology. 4:1991;57-64.
36. Ruppert S., Cole T.J., Boshart M., Schmid W., Schutz G. Multiple mRNA isoforms of the transcription factor CREB Generation by alternative splicing and specific expression in primary spermatocytes . EMBO J. 11:1992;1503-1512.
37. Sapolsky R.M. Glucocorticoids and atrophy of the human hippocampus. Science. 273:1996;749-750.
38. Sapolsky R.M., Uno H., Robert C.S., Finsh C.E. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci. 10:1990;2897-2902.
39. Sheline Y.I., Wany P., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA. 93:1996;3908-3913.
40. Siuciak J.A., Altar C.A., Wiegand S.J., Lindsay R.M. Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3. Brain Res. 633:1994;326-330.
41. Siuciak J.A., Lewis D.R., Wiegand S.J., Lindsay R.M. Antidepressant-like effect of brain derived neurotrophic factor (BDNF). Pharmacol Biochem Behav. 56:1996;131-137.
42. Sleight A.J., Marsden C.A., Palfreyman M.G., Mir A.K., Lovenberb W. Chronic MAO A and MAO B inhibition decreases 5-HT1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase. Eur J Pharmacol. 154:1988;255-261.
43. Sleight A.J., Carolo C., Petit N., Zwingelstein C., Bourson A. Identification of 5-hydroxytryptamine 7 receptor binding sites in rat hypothalamus Sensitivity to chronic antidepressant treatments . Mol Pharmacol. 47:1995;99-103.
44. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress alters the express of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 15:1995;1768-1777.
45. Sunahara R.K., Dessauaer C.W., Gilman A.G. Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol. 36:1996;461-480.
46. Thoenen H. Neurotrophins and neuronal plasticity. Science. 270:1995;593-598.
47. Torres G.E., Chaput Y., Andrade R. Cyclic AMP and protein kinase A mediate 5-HT4 receptor regulation of calcium-activated potassium current in adult hippocampal neurons. Mol Pharmacol. 47:1995;191-197.
48. 2A receptor mediated regulation of brain derived neurotrophic factor mRNA in the hippocampus and neocortex. J Neurosci. 17:1997;2785-2795.
49. Vaidya VA, Siuciak J, Du F, Duman RS (in submission): Mossy fiber sprouting and synaptic reorganization induced by chronic administration of electroconvulsive seizure: Role of BDNF.
50. Vetulani J., Sulser F. Action of various antidepressant treatments reduces reactivity of noradrenergic cAMP generating system in limbic forebrain. Nature. 257:1975;495-496.
51. Wachtel H. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors. Neuropharmacology. 22:1983;267-272.
52. Wachtel H., Schneider H.D. Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors. Neuropharmacology. 25:1986;1119-1126.
53. Walker W.H., Fucci L., Habener J.F. Expression of the gene encoding transcription factor cyclic adenosine 3′,5′-monophosphate (cAMP) response element-binding protein (CREB) Regulation by follicle stimulating hormone-induced cAMP signalling in primary rat sertoli cells . Endocrinology. 136:1995;3534-3545.
54. Watanabe Y., Gould E., Daniels D.C., Cameron H., McEwen B.S. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol. 222:1992;157-162.
55. Widnell K.L., Russell D.S., Nestler E.J. Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc Natl Acad Sci USA. 91:1994;10947-10951.
56. Wooley C.S., Gould E., McEwen B.S. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 531:1990;225-231.
57. Young E.A., Haskett R.F., Murphy-Weinberg V., Watson S.J., Akil H. Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry. 48:1991;693-699.